Trazimera 440 mg

Trastuzumab 440 mg powder for solution is a cancer treatment medication used to target specific proteins in certain breast and stomach cancers. It is administered intravenously and is part of the TRAZIMERA brand.

Trastuzumab is primarily used in the treatment of specific types of breast and stomach cancers. It works by targeting and blocking the action of a protein called HER2, which can help slow or stop the growth of cancer cells. This medication is often used in combination with other cancer treatments.

Common effects of trastuzumab may include fatigue, nausea, and pain at the injection site. Some individuals may also experience fever, chills, or weakness. These effects can vary from person to person and may not occur in everyone who uses the medication.

Trastuzumab should be handled with care and administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions you have before starting treatment. Regular monitoring may be required during therapy.

Trastuzumab may interact with other medications, including those that affect the immune system or other cancer treatments. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect how trastuzumab works.